Chronic Kidney Disease Trial, Recruiting (NCT05878171)

Chronic Kidney Disease Trial, Recruiting NCT05878171 Sponsor: National Taiwan University Hospital Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05878171 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are over 20 years old.
You have been diagnosed with severe chronic kidney disease (stage 5) or end-stage kidney failure, with kidneys functioning at less than 15% of normal capacity, OR you are already receiving regular dialysis treatment (either haemodialysis or peritoneal dialysis).
You have normal cognitive function — for example, you are able to read newspapers or magazines and hold a conversation — and you can communicate in Mandarin or Taiwanese.

Who may not be able to join:

You have severe difficulties with thinking, memory, vision, or hearing that would make it hard to answer questions.
You are currently critically ill.
You have a long-term mental health condition or have a medical record of such a diagnosis.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chan-Shiuan Kuo, National Taiwan University Hospital

Phone: +886-2-23123456 Ext. 262489

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05878171

Sponsor: National Taiwan University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: +886-2-23123456 Ext. 262489

More information: https://clinicaltrials.gov/study/NCT05878171

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are over 20 years old.
You have been diagnosed with severe chronic kidney disease (stage 5) or end-stage kidney failure, with kidneys functioning at less than 15% of normal capacity, OR you are already receiving regular dialysis treatment (either haemodialysis or peritoneal dialysis).
You have normal cognitive function — for example, you are able to read newspapers or magazines and hold a conversation — and you can communicate in Mandarin or Taiwanese.

Who may not be able to join:

You have severe difficulties with thinking, memory, vision, or hearing that would make it hard to answer questions.
You are currently critically ill.
You have a long-term mental health condition or have a medical record of such a diagnosis.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Taiwan University Hospital

Registry

ClinicalTrials.gov

Start date

22 April 2023

Est. completion

30 April 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Preference for end-of-life life-sustaining treatment for patients with end-stage renal disease; The influencing factors of life-sustaining treatment preference in patients with end-stage renal disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov